Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chile weighs adherence to AUGE guarantees

This article was originally published in Clinica

Executive Summary

Cataract surgery accounts for the bulk of the – albeit small – incidence of delayed care in Chile that is seen as being in breach of the country's "universal healthcare access guarantees" (AUGE) programme. This information, of which the health ministry is aware, is contained in a report produced for it by the Fonasa healthcare fund. The recently-released report constitutes the first appraisal of the level of adherence to AUGE's legally-binding principles. Fully 98.8% of services commissioned in 2008 were provided in accordance with its guarantees on timing. The remainder, ostensibly commissioned specifically as a result of "delay, increased risk or non-adherence", totalled almost 28,000 cases. 90% of these were covered by the private sector.

You may also be interested in...



Piramal Profits As It Sheds DRG To Clarivate For $950m

An experienced hand at M&A, Ajay Piramal has done it again – this time selling Decision Resources Group to Clarivate Analytics for $950m. Apart from $900m in cash, Piramal Enterprises will get a stake in Clarivate while the latter expects the acquisition to be earnings-accretive in 2020.

QUOTED. 20 January 2020. Henrik Berggren.

San Francisco-based digital health start-up Steady Health has launched the first "virtual" full-service diabetes clinic for patients in California. See what Henrik Berggren, CEO and founder of Steady Health, said about it here.

China Commits To Patent Linkage And Extensions In US Trade Deal

The first phase of a major trade agreement just signed by the US and China obliges the latter to implement a system linking pharma patent enforcement to marketing authorization procedures as well as to offer patent-term extensions. 

 

Topics

UsernamePublicRestriction

Register

MT041632

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel